Omicia Inc - CA Alameda, Emeryville 94608

Omicia Inc entered the industry of Medical Research in 2002 and has grown to employ 1 to 4 people, generating an annual revenue of $500.000 to $999.999. The NAICS classifies this business under the code 6219992, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.

To acquire more information, please contact Mike Aicher, Chief Executive Officer by calling (510) 595-0800 during business hours. You can also write to the business’ Single Location at 2200 Powell St # 525, Emeryville, California CA 94608. You can also visit the company’s website at omicia.com. View this business’ social media profiles on Twitter or on Facebbok .

Company: Omicia Inc
Representative: Mike Aicher, Chief Executive Officer
Place of Business: 2200 Powell St # 525, Emeryville, CA 94608
Contact Number: (510) 595-0800
Website: omicia.com
Type of Service: Medical Research
SIC Number: 8733
NAICS Number: 6219992
Locality: Single Location
Market Type: B2B (Business to Business)
Began: 2002
Income/Year: $500.000 to $999.999
Laborers: 1 to 4
Share This Company:

Omicia Inc is a company operating from Alameda, California providing professional Medical Research and relevant B2B variables. It was founded in 2002 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 6219992 as Medical Research.

With a current employee count of 1 to 4, Omicia Inc has gone to report making $500.000 to $999.999 per annum on its journey towards growth. This company invites you to contact its representative Mike Aicher, Chief Executive Officer at (510) 595-0800 for related queries, or to locate its Single Location using the coordinates 37.83719,-122.301503.

The Single Location can also be found at the street address 2200 Powell St # 525 in Emeryville, California 94608 and can be engaged online through the company website at omicia.com, the company Twitter , and Facebook page .